In addition to regulating HSP90 signalling, 17-AAG leads to depletion of oncogenic proteins involved in multiple pathways, of which NF-κB and MAPK pathways can be activated in 17-AAG-resistant breast cancer cells 29. This evidence concerns the gene HSP90AA1 and breast carcinoma.